263 related articles for article (PubMed ID: 33919088)
21. Exploring neuroprotective potential of Withania somnifera phytochemicals by inhibition of GluN2B-containing NMDA receptors: An in silico study.
Kumar G; Patnaik R
Med Hypotheses; 2016 Jul; 92():35-43. PubMed ID: 27241252
[TBL] [Abstract][Full Text] [Related]
22. Withaferin A induces apoptosis by ROS-dependent mitochondrial dysfunction in human colorectal cancer cells.
Xia S; Miao Y; Liu S
Biochem Biophys Res Commun; 2018 Sep; 503(4):2363-2369. PubMed ID: 29966656
[TBL] [Abstract][Full Text] [Related]
23. Withaferin-A--A Natural Anticancer Agent with Pleitropic Mechanisms of Action.
Lee IC; Choi BY
Int J Mol Sci; 2016 Mar; 17(3):290. PubMed ID: 26959007
[TBL] [Abstract][Full Text] [Related]
24. Withaferin A: From Ancient Remedy to Potential Drug Candidate.
Sultana T; Okla MK; Ahmed M; Akhtar N; Al-Hashimi A; Abdelgawad H; Haq IU
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946778
[TBL] [Abstract][Full Text] [Related]
25. Keeping abreast about ashwagandha in breast cancer.
Vashi R; Patel BM; Goyal RK
J Ethnopharmacol; 2021 Apr; 269():113759. PubMed ID: 33359916
[TBL] [Abstract][Full Text] [Related]
26.
Lee DH; Ahn J; Jang YJ; Seo HD; Ha TY; Kim MJ; Huh YH; Jung CH
Nutrients; 2020 Feb; 12(2):. PubMed ID: 32046183
[No Abstract] [Full Text] [Related]
27. On the action and mechanism of withaferin-A from Withania somnifera, a novel and potent melanin dispersing agent in frog melanophores.
Ali SA; Meitei KV
J Recept Signal Transduct Res; 2011 Oct; 31(5):359-66. PubMed ID: 21848494
[TBL] [Abstract][Full Text] [Related]
28. Pharmacologic overview of Withania somnifera, the Indian Ginseng.
Dar NJ; Hamid A; Ahmad M
Cell Mol Life Sci; 2015 Dec; 72(23):4445-60. PubMed ID: 26306935
[TBL] [Abstract][Full Text] [Related]
29. Pharmacological evaluation of Ashwagandha highlighting its healthcare claims, safety, and toxicity aspects.
Mandlik Ingawale DS; Namdeo AG
J Diet Suppl; 2021; 18(2):183-226. PubMed ID: 32242751
[No Abstract] [Full Text] [Related]
30. Evaluating the inhibitory potential of Withania somnifera on platelet aggregation and inflammation enzymes: An in vitro and in silico study.
M M; Zameer F; Naidu A; M N NP; Dhananjaya BL; Hegdekatte R
Pharm Biol; 2016 Sep; 54(9):1936-41. PubMed ID: 26704448
[TBL] [Abstract][Full Text] [Related]
31. Cytotoxic Withanolides from the Roots of Indian Ginseng ( Withania somnifera).
Kim S; Yu JS; Lee JY; Choi SU; Lee J; Kim KH
J Nat Prod; 2019 Apr; 82(4):765-773. PubMed ID: 30776236
[TBL] [Abstract][Full Text] [Related]
32. Anticancer activities of Withania somnifera: Current research, formulations, and future perspectives.
Rai M; Jogee PS; Agarkar G; dos Santos CA
Pharm Biol; 2016; 54(2):189-97. PubMed ID: 25845640
[TBL] [Abstract][Full Text] [Related]
33. Phyto-therapeutic potential of Withania somnifera: Molecular mechanism and health implications.
Yadav N; Tripathi S; Sangwan NS
Phytother Res; 2024 Mar; 38(3):1695-1714. PubMed ID: 38318763
[TBL] [Abstract][Full Text] [Related]
34. A Perspective on
Dubey S; Singh M; Nelson A; Karan D
J Immunol Res; 2021; 2021():9483433. PubMed ID: 34485538
[TBL] [Abstract][Full Text] [Related]
35. Withanolides from Withania somnifera Dunal: development of cellular technology and their production.
Sangwan NS; Sabir F; Mishra S; Bansal S; Sangwan RS
Recent Pat Biotechnol; 2014; 8(1):25-35. PubMed ID: 24354530
[TBL] [Abstract][Full Text] [Related]
36. Molecular docking, QSAR and ADMET studies of withanolide analogs against breast cancer.
Yadav DK; Kumar S; Saloni ; Singh H; Kim MH; Sharma P; Misra S; Khan F
Drug Des Devel Ther; 2017; 11():1859-1870. PubMed ID: 28694686
[TBL] [Abstract][Full Text] [Related]
37. Withaferin A suppresses breast cancer cell proliferation by inhibition of the two-pore domain potassium (K2P9) channel TASK-3.
Zúñiga R; Concha G; Cayo A; Cikutović-Molina R; Arevalo B; González W; Catalán MA; Zúñiga L
Biomed Pharmacother; 2020 Sep; 129():110383. PubMed ID: 32563149
[TBL] [Abstract][Full Text] [Related]
38. Structure-based design, synthesis, and biological evaluation of withaferin A-analogues as potent apoptotic inducers.
Llanos GG; Araujo LM; Jiménez IA; Moujir LM; Rodríguez J; Jiménez C; Bazzocchi IL
Eur J Med Chem; 2017 Nov; 140():52-64. PubMed ID: 28923386
[TBL] [Abstract][Full Text] [Related]
39. Withaferin A attenuates bleomycin-induced scleroderma by targeting FoxO3a and NF-κβ signaling: Connecting fibrosis and inflammation.
Bale S; Pulivendala G; Godugu C
Biofactors; 2018 Nov; 44(6):507-517. PubMed ID: 30367690
[TBL] [Abstract][Full Text] [Related]
40. Withania somnifera (L.) Dunal - Modern perspectives of an ancient Rasayana from Ayurveda.
Mukherjee PK; Banerjee S; Biswas S; Das B; Kar A; Katiyar CK
J Ethnopharmacol; 2021 Jan; 264():113157. PubMed ID: 32783987
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
